Health News from Reuters
 Back to health news main page
|
 |
| 65 results found Results 1-5 | Next 5 results |
September 10, 2010 headlines
US again funding controversial stem cell research
WASHINGTON (Reuters) - The U.S. government said it was resuming work on controversial human embryonic stem cell research on Friday after an appeals court ruled in its favor.
Enriched soybean oil provides fish-free omega-3s
NEW YORK (Reuters Health) - Enriched soybean oil may be a sustainable alternative to fish oil for obtaining heart-healthy omega-3s, suggests a new Monsanto study.
Treatments for genital pain no better than placebo
NEW YORK (Reuters Health) - Two standard therapies for a type of genital pain in women may be no more effective than a placebo, a new clinical trial suggests.
USDA knew of problems at egg recall farm: report
BANGALORE (Reuters) - U.S. Department of Agriculture experts knew about sanitary problems at one of the two Iowa farms at the center of a massive nationwide egg recall, but did not notify health authorities, the Wall Street Journal reported.
UK's NICE wants more data on schizophrenia drug
LONDON (Reuters) - Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.
| Next 5 results |